Proscia, DoMore Diagnostics Partner for Improved Colorectal Cancer Treatment

Proscia has partnered with DoMore Diagnostics to help pathologists predict outcomes for colorectal cancer (CRC) patients. The collaboration paves the way for integrating AI-powered clinical decision support into routine pathology workflows, unlocking new insights that can guide increasingly precise treatment decisions and ensure patients receive optimal care.